Association of Burkitt's Lymphoma with the Epstein-Barr Virus in Two Developing Countries

References

• de The G. The Epstein-Barr Virus and Burkitt's lymphoma worldwide: the causal relationship revisited. Burkitt's lymphoma- a human cancer model, G. M.G. Lenoir, T. O'Conor, C. L. M. Olweny. International Agency for Research on Cancer, Lyon 1985; 165–176, IARC Scientific Publication No 60
   Google Scholar
• Jaffe E. S., Diebold J., Harris N. L., Muller-Hermelink H-K., Flandrin G., Vardiman J. W. Burkitt's lymphoma. A single disease with multiple variants. Blood 1999; 93: 1124–1125
   PubMed Web of Science ®Google Scholar
• Magrath I. T. African Burkitt's lymphoma. History, biology, clinical features and treatment. Am J Pediatr Hematol Oncol 1991; 13: 222–246
   PubMedGoogle Scholar
• Magrath I. T., Jain V., Bhatia K. Epstein-Barr virus and Burkitt's lymphoma. Semin Cancer Biol 1992; 3: 285–295
   PubMedGoogle Scholar
• Anaissie E., Geha S., Allam C., Jabour J., Khalyl M., Salem P. Burkitt's lymphoma in the Middle East. Burkitt's lymphoma-a human cancer model, G. M. Lenoir, G T. O'Conor, C. L. M. Olweny. International Agency for Research on Cancer, Lyon 1985; 107–118, IARC Scientific Publication No. 60
   Google Scholar
• Al-Attar A., Al-Mondhiry H., Al-Bahrani Z., Al-Saleem T. Burkitt's lymphoma in Iraq. Clinical and pathological study of forty-seven patients. Int J Cancer 1979; 23: 14–17
   PubMed Web of Science ®Google Scholar
• Mansoor A., Stetler Stevenson M., Li R. Z., Frekko K., Weiss W., Ahmed M., Khan A. H., Mushtaq S., Saleem M., Raffeld M., Kingma D. W., Jaffe E. S. Prevalence of Epstein-Barr viral sequences and EBV LMP1 oncogene deletions in Burkitt's lymphoma from Pakistan: Epidemiological correlations. Hum Pathol 1997; 28: 283–288
   PubMed Web of Science ®Google Scholar
• Anwar N., Kingma D. W., Bloch A. R., Mourad M., Raffeld M., Franklin J., Magrath I., El Bolkainy N., Jaffe E. S. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt. Epidemiologic considerations. Cancer 1995; 76: 1245–1252
   PubMed Web of Science ®Google Scholar
• Cavdar A. O., Yavuz G., Babacab E., Gozdasoglu S., Unal E., Ertem U., Pamir A., Yucesan S., Gokcora H., Uluoglu O., Ikinciogullari A. Burkitt's lymphoma in Turkish children: clinical viral (EBV) and molecular studies. Leuk Lymphoma 1994; 14: 323–330
   PubMed Web of Science ®Google Scholar
• Ertem U., Duru F, Pamir A., Tacyildiz N., Dagdemir A., Akcayoz A., Uluoglu O., Tezic T. Burkitt's lymphoma in 63 Turkish children diagnosed over a 10 year period. Ped Hematol Oncol 1996; 13: 123–134
   PubMed Web of Science ®Google Scholar
• Cavdar A. O., Gozdasoglu S., Yavuz G., Babacan E., Unal E., Uluoglu O., Yucesan S., Magrath I. T., Akar N. Burkitt's lymphoma between African and American types in Turkish children: clinical, viral (EBV) and molecular studies. Med Pediatr Oncol 1993; 21: 36–42
   PubMedGoogle Scholar
• Chao T. Y., Wang T. Y., Lee W. H. Association between Epstein-Barr virus and Burkitt's lymphoma in Taiwan. Cancer 1997; 80: 121–128
   PubMed Web of Science ®Google Scholar
• Sandlund J. T., Fonseca T., Leimig T., Verissimo L., Ribeiro R., Lira V., Berard C. W., Sixbey J., Crist W. M., Mao L., Chen G., Pui C. H., Heim M., Pedrosa F. Predominance and characteristics of Burkitt lymphoma among children with non-Hodgkin lymphoma in northeastern Brazil. Leukemia 1997; 11: 743–746
   PubMed Web of Science ®Google Scholar
• Bacchi M. M., Bacchi C. E., Alvarenga M., Miranda R. R., Chen Y-Y., Weiss L. M. Burkitt's lymphoma in Brazil. Strong association with Epstein-Barr virus. Mod Pathol 1996; 9: 63–67
   PubMed Web of Science ®Google Scholar
• Chen W-G., Chen Y-Y., Bacchi M. M., Bacchi C. E., Alvarenga M., Weiss L. M. Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue. Type A with a high prevalence of deletion within the latent membrane protein gene. Amer J Pathol. 1996; 148: 17–23
   PubMed Web of Science ®Google Scholar
• Gutierrez M. I., Bhatia K., Barriga F., Drez B., Huriel F. S., Andreas M. L., Epelman S., Risireno C., Magrath I. T. Molecular epidemiology of Burkitt's lymphoma from South America: differences in breakpoint location and Epstein-Barr virus association from tumors in other world regions. Blood 1992; 79: 3261–3266
   PubMed Web of Science ®Google Scholar
• Smith R. D. Is Epstein-Barr virus a human oncogene or only an innocent bystander?. Hum Pathol. 1997; 23: 1331–1335
   Google Scholar
• Kieff E. Epstein-Bari virus and It's Replication. Field's Virology, B. N. Fields, D. M. Knipe, P. M. Howley. Lippincott-Raven, Philadelphia 1996; 2343–2396
   Google Scholar
• Young L. S., Yao Q. Y., Roponey C. M., Sculley T. B., Moss Rupani D. J.H., Laux G., Bornkam G. W. New type B isolate of Epstein-Barr virus from Burkitt's lymphoma aid normal individuals in endemic areas. J Gen Virol. 1987; 68: 2853–2862
   PubMed Web of Science ®Google Scholar
• Boyle M. J., Sewell W. A., Sculley T. K., Apolloni A., Turner J. J., Swanson C. E., Penny R., Cooper D. A. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood 1991; 78: 3004–3011
   PubMed Web of Science ®Google Scholar
• Goldschimidts W., Bhatia K., Johnson J. F., Akar N., Gutierrez M. I., Shibata D., Carolan M., Levine A., Magrath I. T. Epstein-Barr virus in AIDS-associated lymphomas are similar to those in endemic Burkitt. Lymphoma Leukemia 1992; 6: 875–878
   PubMed Web of Science ®Google Scholar
• Kingma D. W., Weis W. B., Jaffe E. S., Kumar Frekko S. K., Raffeld M. Epstein Barr virus latent membrane protein-I oncogene deletions: correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996; 88: 242–251
   PubMed Web of Science ®Google Scholar
• Knecht H., Martius F, Bachmann E., Hoffman T., Zimmerman D. R., Rothenberger S., Sandvej K., Wegmann W., Hurwitz N., Odermatt B. F., et al. A deletion mutant of the LMP-1 oncogene of Epstein-Barr virus is associated with evolution of angioimmununoblastic lymphadenopathy into B immunoblastic lymphoma. Leuhemia 1995; 9: 458–465
   Google Scholar
• Hayashi K., Chen W-G., Chen Y-Y., Bacchi M. M., Bacchi C. E., Alvarenga M., Abreu E. S., Chang K. L, Welsh L. M. Deletion of Epstein-Barr virus latent membrane protein I gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: High frequency of a 30-bp deletion. Hum Pathol 1997; 28: 1408–1114
   PubMed Web of Science ®Google Scholar
• Drut R. M., Day S., Drut R., Meisner L. Demonstration of Epstein-Barr viral DNA in paraffin-embedded tissues of Burkitt's lymphoma from Argentina using the polymerase chain reaction and in-situ hybridization. Pediatr Pathol. 1994; 14: 101–109
   PubMed Web of Science ®Google Scholar
• Guttierrz M. I., Hamdy N., Bhatia K., Bornkam G., Lenoir G., Epelman S., Magrath I. Geographic variation in t(8:14) chromosomal breakpoint location, and EBV association in Burkitt's lymphoma. Int J Ped Hematol Oncol 1999; 6: 161–168
   Web of Science ®Google Scholar
• Abreu M. A., Baroza L. G. V., Rossi M. A. Toluidine blue-basic fuchsin stain for glycolmethacrylate embedded tissue. The J Histotechnol 1993; 16: 139–140
   Web of Science ®Google Scholar
• Wu T. C., Mann R. B., Epstein J. I., MacMahon E., Lee W. A., Charache P., Hayward S. D., Kurman R. J., Hayward G. S., Ambinder R. F. Abundant expression of EBERI small nuclear RNA in nasopharyngeal carcinoma. Amer J Pathol 1991; 138: 1461–1469
   PubMed Web of Science ®Google Scholar
• Preciado M. V., Dc Mattco E., Diez B., Menarguez J., Grinstein S. Presence of Epstein-Barr virus and strain type assignment in Argentine childhood Hodgkin's disease. Blood 1995; 86: 3922–3929
   PubMed Web of Science ®Google Scholar
• Magrath I. T., Bhatia K. Pathogenesis of small non-cleaved cell lymphoma (Burkitt's lymphoma. The Non-Hodgkin's Lymphomas, Second edition, I T. Magrath. Arnold, London, Sydney, Auckland 1997; 384–409
   Google Scholar
• Chan J. K. C., Tsang W. Y. W., Ng C. S., Wong C. S. C., Lo E. S. F. A study of the association of Epstein-Barr virus with Burkitt's lymphoma occurring in a Chinese population. Histopathol. 1995; 26: 239–245
   PubMed Web of Science ®Google Scholar
• Dirnhofer S., Angeles-Angeles A., Ortiz-Hidalgo C., Reyes E., Gredler E., Krugmann J., Fend F, Quintanilla-Martinez L. High prevalence of a 30-base pair deletion in the Epstein-Barr Virus (EBV) latent membrane protein I gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue. Hum Pathol 1999; 30: 781–787
   PubMed Web of Science ®Google Scholar
• Moorthy R. K., Thorley-Lawson D. A. All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of Rat-1 fibroblasts. J Virol. 1993; 67: 1638–1646
   PubMed Web of Science ®Google Scholar
• Kaye K., Izumi K., Kieff E. Epstein-Barr virus latent membrane protein-I is essential for B-lymphocyte growth transformation. proc Natl Acad Sci USA 1993; 90: 9150–9154
   PubMed Web of Science ®Google Scholar
• Young L. S., Rowe M. Epstein-Barr virus, lymphomas and Hodgkin's disease. Seminar in Cancer Biology 1992; 3: 273–284
   PubMedGoogle Scholar
• Itakura O., Yamada S., Narita M., Kikuta H. High prevalence of a 30-base pair deletion and single-base mutations within the carboxy terminal end of the LMP–I oncogene of Epstein-Barr virus in the Japanese population. Oncogene 1996; 13: 1549–1553
   PubMed Web of Science ®Google Scholar
• Khanim E, Yao Q-Y., Niedobitek G., Sihota S., Rickinson A. B., Young L. S. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 1996; 88: 3491–3501
   PubMed Web of Science ®Google Scholar
• Sandvej K., Peh S-C., Andersen B. S. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-I gene in both malignant and benign EBV-associated diseases. High frequency of a 30bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 1994; 84: 4053–4060
   PubMed Web of Science ®Google Scholar
• Leung S. Y., Yuen S. T., Chung L. P., Chan A. S. Y., Wong M. P. Prevalence of mutations and 30-bp deletions in the C-terminal region of Epstein-Barr virus latent membrane protein-I oncogene in reactive lymphoid tissue and non-nasopharyngeal EBV-assocated carcinomas in Hong-Kong Chinese. Int J Cancer 1997; 72: 225–230
   PubMed Web of Science ®Google Scholar
• Chang Y-S., Su I-J., Chung P. J., et al. Detection of an Epstein-Barr- virus variant in T-cell lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population. Int J Cancer 1995; 62: 673–677
   PubMed Web of Science ®Google Scholar
• Miller W E., Edwards R. H., Walling D. M., Raab-Traub N. N. Sequence variation in the Epstein-Barr virus latent membrane protein I. J Gen Virol. 1994; 75: 2729–2740
   PubMed Web of Science ®Google Scholar
• Oshima M., Azuma H., Okuno A. High prevalence of Epstein-Barr virus type A strain with the 30 b.p. deletion of the latent membrane protein-I gene in a Japanese population. Pediatr Int 1999; 41: 490–495
   PubMed Web of Science ®Google Scholar